Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304891453> ?p ?o ?g. }
- W4304891453 endingPage "215" @default.
- W4304891453 startingPage "204" @default.
- W4304891453 abstract "This study aimed to estimate the cost-effectiveness of the use of recombinant zoster vaccine (RZV) (Shingrix), which protects against herpes zoster (HZ), among immunocompromised adults aged 19 to 49 years, as a contribution to deliberations of the Advisory Committee on Immunization Practices.Hematopoietic cell transplant (HCT) recipients experience a high incidence of HZ, and the efficacy of RZV in preventing HZ has been studied in clinical trials. The cost-effectiveness model calculated incremental cost-effectiveness ratios that compared vaccination with RZV with a no vaccination strategy among adults aged 19 to 49 years. Costs and outcomes were calculated until age 50 years using the healthcare sector perspective and summarized as cost per quality-adjusted life-year (QALY) gained. The base case represents HCT recipients, with scenario analyses representing persons with other immunocompromising conditions, including hematologic malignancies, human immunodeficiency virus, and autoimmune and inflammatory conditions. Uncertainty was investigated using univariate, multivariate, and probabilistic sensitivity analyses.Base-case results indicated vaccination with RZV would avert approximately 35% of HZ episodes and complications, while saving approximately 11% of net costs. Compared with no vaccination, vaccination of HCT recipients with RZV generated cost-savings (ie, lower costs and improved health) in the base case and in 81% of simulations in the probabilistic analysis. In scenario analyses, vaccination cost US dollar ($) 9500/QALY among patients with hematologic malignancies, $79 000/QALY among persons living with human immunodeficiency virus, and $208 000/QALY among persons with selected autoimmune and inflammatory conditions.Generally favorable economic estimates supported recommendations for vaccination of immunocompromised adults with RZV to prevent episodes of HZ and related complications." @default.
- W4304891453 created "2022-10-13" @default.
- W4304891453 creator A5015338619 @default.
- W4304891453 creator A5020815537 @default.
- W4304891453 creator A5060787988 @default.
- W4304891453 creator A5062822986 @default.
- W4304891453 creator A5064210836 @default.
- W4304891453 creator A5080407061 @default.
- W4304891453 creator A5081055053 @default.
- W4304891453 creator A5089050580 @default.
- W4304891453 date "2023-02-01" @default.
- W4304891453 modified "2023-10-16" @default.
- W4304891453 title "Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years" @default.
- W4304891453 cites W1979871017 @default.
- W4304891453 cites W2000129666 @default.
- W4304891453 cites W2009736529 @default.
- W4304891453 cites W2010207831 @default.
- W4304891453 cites W2019495058 @default.
- W4304891453 cites W2033062403 @default.
- W4304891453 cites W2045966709 @default.
- W4304891453 cites W2086454732 @default.
- W4304891453 cites W2092864547 @default.
- W4304891453 cites W2109333912 @default.
- W4304891453 cites W2114213842 @default.
- W4304891453 cites W2118705380 @default.
- W4304891453 cites W2124903732 @default.
- W4304891453 cites W2136116913 @default.
- W4304891453 cites W2297608701 @default.
- W4304891453 cites W2304271222 @default.
- W4304891453 cites W2581789142 @default.
- W4304891453 cites W2591213951 @default.
- W4304891453 cites W2615762503 @default.
- W4304891453 cites W2621741324 @default.
- W4304891453 cites W2781747798 @default.
- W4304891453 cites W2784682748 @default.
- W4304891453 cites W2806780319 @default.
- W4304891453 cites W2883596402 @default.
- W4304891453 cites W2898345022 @default.
- W4304891453 cites W2903470563 @default.
- W4304891453 cites W2915317333 @default.
- W4304891453 cites W2915567672 @default.
- W4304891453 cites W2953782237 @default.
- W4304891453 cites W2960588225 @default.
- W4304891453 cites W2965743944 @default.
- W4304891453 cites W2966872618 @default.
- W4304891453 cites W2969978602 @default.
- W4304891453 cites W2980306616 @default.
- W4304891453 cites W2984774302 @default.
- W4304891453 cites W3126710197 @default.
- W4304891453 cites W3186328747 @default.
- W4304891453 cites W3193217324 @default.
- W4304891453 cites W4206408785 @default.
- W4304891453 cites W4247276518 @default.
- W4304891453 doi "https://doi.org/10.1016/j.jval.2022.08.003" @default.
- W4304891453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36243666" @default.
- W4304891453 hasPublicationYear "2023" @default.
- W4304891453 type Work @default.
- W4304891453 citedByCount "1" @default.
- W4304891453 countsByYear W43048914532023 @default.
- W4304891453 crossrefType "journal-article" @default.
- W4304891453 hasAuthorship W4304891453A5015338619 @default.
- W4304891453 hasAuthorship W4304891453A5020815537 @default.
- W4304891453 hasAuthorship W4304891453A5060787988 @default.
- W4304891453 hasAuthorship W4304891453A5062822986 @default.
- W4304891453 hasAuthorship W4304891453A5064210836 @default.
- W4304891453 hasAuthorship W4304891453A5080407061 @default.
- W4304891453 hasAuthorship W4304891453A5081055053 @default.
- W4304891453 hasAuthorship W4304891453A5089050580 @default.
- W4304891453 hasConcept C112930515 @default.
- W4304891453 hasConcept C187212893 @default.
- W4304891453 hasConcept C203014093 @default.
- W4304891453 hasConcept C22070199 @default.
- W4304891453 hasConcept C2780441014 @default.
- W4304891453 hasConcept C3019080777 @default.
- W4304891453 hasConcept C515549039 @default.
- W4304891453 hasConcept C71924100 @default.
- W4304891453 hasConceptScore W4304891453C112930515 @default.
- W4304891453 hasConceptScore W4304891453C187212893 @default.
- W4304891453 hasConceptScore W4304891453C203014093 @default.
- W4304891453 hasConceptScore W4304891453C22070199 @default.
- W4304891453 hasConceptScore W4304891453C2780441014 @default.
- W4304891453 hasConceptScore W4304891453C3019080777 @default.
- W4304891453 hasConceptScore W4304891453C515549039 @default.
- W4304891453 hasConceptScore W4304891453C71924100 @default.
- W4304891453 hasIssue "2" @default.
- W4304891453 hasLocation W43048914531 @default.
- W4304891453 hasLocation W43048914532 @default.
- W4304891453 hasOpenAccess W4304891453 @default.
- W4304891453 hasPrimaryLocation W43048914531 @default.
- W4304891453 hasRelatedWork W1978145704 @default.
- W4304891453 hasRelatedWork W2001870732 @default.
- W4304891453 hasRelatedWork W2035295984 @default.
- W4304891453 hasRelatedWork W2045808882 @default.
- W4304891453 hasRelatedWork W2111358957 @default.
- W4304891453 hasRelatedWork W2800791464 @default.
- W4304891453 hasRelatedWork W2802137233 @default.
- W4304891453 hasRelatedWork W2978324409 @default.
- W4304891453 hasRelatedWork W3193693521 @default.